Heron Therapeutics Inc vs Toronto-Dominion Bank — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 3261.4× Heron Therapeutics Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | TD | |
|---|---|---|
Market Cap | $61.47M | $200.48B |
Sector | Health | Financials |
52-Week High | $1.49 | $124.80 |
52-Week Low | $0.32 | $72.85 |
Enterprise Value | $168.21M | — |
Dividend Yield | — | 2.63% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →